About ABX

Welcome to the worldwide leading supplier of PET precursors and reagent kits.

ABX is a trusted partner in radiopharmaceutical innovation, providing end-to-end expertise across the entire value chain - from early research and development to clinical manufacturing, regulatory support, commercialization and global supply.

As market leader for radiopharmaceutical products, we developed the ¹⁷⁷Lu-PSMA-617 – until clinical phase II (sublicense Novartis) as well as ¹⁸F-PSMA-1007 - now approved in selected countries in Europe, Asia and North Africa.

ABX – Trusted Excellence from Molecule to Market

Our integrated portfolio includes radiopharmaceuticals, CDMO / CMO services and products, enabling customers to simplify complex processes with one experienced partner. Built on GMP-compliant manufacturing, uncompromising quality standards and a collaborative mindset, we are a fully trusted deliverer of reliable solutions for even the most demanding projects.

With 30 years of experience, ABX combines scientific excellence, regulatory expertise and operational precision to help customers bring innovative radiopharmaceutical solutions to patients faster.

Trusted Excellence defines how we work - advancing nuclear medicine and improving patient care worldwide.

Funding from the EU and the Free State of Saxony: Support for soil rehabilitation in preparation for the upcoming expansion of ABX’s facility in Radeberg

By purchasing land to expand its production capacity in Radeberg, ABX is making a targeted investment in a sustainable business location.
The project thus makes an important contribution to the sustainable development of Radeberg as a business hub and to strengthening regional economic growth.
Funding from the European Union and the Free State of Saxony will enable the decontamination of the site, paving the way for its economic development in an environmentally responsible manner.
Site decontamination is a key component of ABX’s planned expansion in Radeberg. The contamination in the subsoil stems from the site’s historical use, as it was home to a glassworks until 1928.
The goal of this project is to remove the historical soil contamination. This lays the groundwork for a sustainable expansion of the company’s site, ensuring safe and healthy working conditions in the future.

The project is funded by the European Union and the Free State of Saxony.

The project is receiving financial support from the European Union and the Free State of Saxony. The core of the project involves decontamination through soil replacement.

This process entails excavating a large portion of the contaminated soil and either recycling it properly or disposing of it in a manner that is compatible with the public interest. Any residual contamination remaining in the subsoil will be properly secured. A prerequisite for this is the prior demolition of the existing buildings on the site.

Following the remediation work, at least 15 percent of the decontaminated area is to be restored to its natural state. At the same time, new production facilities will be constructed, designed to meet modern technical, safety, and energy efficiency standards.

Funding Information
The project is funded by the European Union and the Free State of Saxony.This measure is co-financed by tax revenues based on the budget approved by the Saxon State Parliament.

Learn more about ABX

At ABX, we continuously advance the development of new radiopharmaceutical solutions – from the initial idea to clinical application. We combine scientific excellence with practical feasibility, turning innovative approaches into market-ready solutions.

ABX Milestones

From a small Lab with 5 employees to a worldwide Trusted Partner, learn more about our History

Corporate Compliance

ABX advanced biochemical compounds is part of the Otsuka Group. As a global company with a worldwide customer base, we are aware of our legal and ethical obligations as well as our environmental and social responsibility

News

Stay Tuned! Get all News and updates from ABX on our news platform

Sustainability

Supporting environmental and social sustainability is a part of our business conduct. We view sustainability as an ongoing process that we can actively shape and that is constantly evolving. This page provides an initial overview of the measures we have already implemented and the progress we have made.